Cited by 254Epigenetics and DNA MethylationGenetic Associations and EpidemiologyHealth, Environment, Cognitive Aging

Epigenetic Epidemiology of Common Complex Disease: Prospects for Prediction, Prevention, and Treatment

Open access
Relton, Caroline L., Davey Smith, George·2010·PLoS Medicine

Abstract

Research in Translation discusses health interventions in the context of translation from basic to clinical research

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1000356

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Epigenetic factors may account for some of the non-explained variance in genetics studies and possibly mediate interactions between genotype and known environmental risk factors in influencing the onset of complex diseases.

    “This suggests that epigenetic factors may account for some of the non-explained variance in genetics studies and possibly mediate the interactions between genotype and known environmental risk factors in influencing the onset of complex diseases (Relton & Smith, 2010).”

    From Can epigenetics shine a light on the biological pathways underlying major mental disorders? (2022) · cites this paper as Relton & Smith, 2010

    The Summary Points say epigenetic variation contributes to variation in common complex disease risk, and the “Genetical Epigenomics” section describes epigenetic variation as a potential mediator of environmental exposures’ effects on disease. The paper does not specifically say that epigenetic factors account for unexplained variance in genetic studies or mediate interactions between genotype and environmental risk factors. No page numbers are available in our copy. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Studying the epigenome in well-characterized samples may enable discovery of novel genes and pathways through which genetic factors and environmental exposures influence disease initiation and development, providing new targets for prevention and treatment.

    “Studying the epigenome in the well-characterized samples may enable us to discover novel genes and pathways through which genetic factors and environmental exposures influence disease initiation and development, and thereby provide new targets for prevention and treatment”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Relton, C. L., & Davey Smith, G.
Affiliations
Newcastle University (GB)
Corresponding author
Relton, Caroline L.
Venue
PLoS Medicine
Published
2010-10-26
Volume
7
Issue
10
Pages
e1000356
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2120462849
Cited by
254
References
89
Citations by year
2026: 6 · 2025: 8 · 2024: 11 · 2023: 6 · 2022: 19 · 2021: 18 · 2020: 18 · 2019: 11 · 2018: 21 · 2017: 12 · 2016: 11 · 2015: 17 · 2014: 23 · 2013: 21 · 2012: 30
FWCI
9.31
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Explore Bristol Research (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Bristol Research (University of Bristol) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by)
Funders
  • Medical Research Council (G0600705)
  • Biotechnology and Biological Sciences Research Council (BB/F007981/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
Keywords
epigenetic epidemiology, complex diseases, disease prediction, disease prevention, treatment, translation research, health interventions
MeSH terms
Disease, Humans, Models, Biological, Preventive Medicine, Prognosis, Therapeutics, Molecular Epidemiology, Rare Diseases, Epigenesis, Genetic, Metagenomics, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review